BLTE
BELITE BIO, INC
BELITE BIO, INC (BLTE) has 8 SEC Form 4 filings (48 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jun 22, 2026.
The most active filer is Chief Scientific Officer MATA NATHAN L. with 6 filings. Insiders have net sold $3.7M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Yu-Hsin Lin
- Employees:25
- HQ:San Diego, CA, US
- IPO:2022-04-29
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.7M
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$6.2B
Price slightly stale
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Medical Officer | Sale | 10,000 | $1.5M | Jun 22 | SEC ↗ | |
Scholl Hendrik PeterFirst filing | Chief Medical Officer | Sale | 10,000 | $1.4M | Jun 17 | SEC ↗ |
| Chief Scientific Officer | Sale | 666 | $102K | May 8 | SEC ↗ | |
| Chief Scientific Officer | Sale | 1,000 | $154K | May 7 | SEC ↗ | |
| Chief Scientific Officer | Sale | 1,000 | $156K | May 6 | SEC ↗ | |
| Chief Scientific Officer | Sale | 1,000 | $156K | May 5 | SEC ↗ | |
| Chief Scientific Officer | Sale | 1,000 | $156K | May 4 | SEC ↗ | |
MATA NATHAN L.First filing | Chief Scientific Officer | Sale | 1,000 | $160K | Apr 27 | SEC ↗ |
Related companies
BELITE BIO, INC is in the Healthcare sector.